161 related articles for article (PubMed ID: 36565970)
21. Protein-protein interactions of HPV-
Khan AA; A Abuderman A; Ashraf MT; Khan Z
Future Microbiol; 2020 May; 15():509-520. PubMed ID: 32476479
[No Abstract] [Full Text] [Related]
22. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
25. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
26. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
27. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
[TBL] [Abstract][Full Text] [Related]
28. Splicing Characterization and Isoform Switch Events in Human Keratinocytes Carrying Oncogenes from High-Risk HPV-16 and Low-Risk HPV-84.
Nasiri-Aghdam M; Garcia-Chagollan M; Pereira-Suarez AL; Aguilar-Lemarroy A; Jave-Suarez LF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176052
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Hong HS; Akhavan J; Lee SH; Kim RH; Kang MK; Park NH; Shin KH
Int J Oral Sci; 2020 Jan; 12(1):3. PubMed ID: 31911577
[TBL] [Abstract][Full Text] [Related]
30. Expression of HPV-16 E6 and E7 oncoproteins alters
Olivera C; Mosmann JP; Anna AN; Bettucci Ferrero GN; Paira DA; Ferreyra FN; Martinez MS; Motrich RD; Cuffini CG; Saka HA; Rivero VE
Front Cell Infect Microbiol; 2023; 13():1214017. PubMed ID: 37743859
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of co-infection with human papillomavirus and Chlamydia trachomatis and risk factors associated with cervical cancer in Congolese women.
Ngombe Mouabata DFL; Boumba ALM; Massengo NRB; Pouki FS; Moukassa D; Ennaji MM
Microbes Infect; 2024; 26(3):105287. PubMed ID: 38163457
[TBL] [Abstract][Full Text] [Related]
32. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
33. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
[TBL] [Abstract][Full Text] [Related]
34. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
35. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
36. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
37. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
38. HPV and Chlamydia trachomatis coinfection in women with Pap smear abnormality: baseline data of the HPV Pathogen ISS study.
Mancini F; Vescio F; Mochi S; Accardi L; di Bonito P; Ciervo A
Infez Med; 2018 Jun; 26(2):139-144. PubMed ID: 29932086
[TBL] [Abstract][Full Text] [Related]
39. A literature review on correlation between HPV coinfection with C. trachomatis and cervical neoplasia - coinfection mediated cellular transformation.
Kumari S; Bhor VM
Microb Pathog; 2022 Jul; 168():105587. PubMed ID: 35588965
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
